HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 14 analysts with an average price target of $9.87. This is a potential upside of $4.24 (75.31%) from yesterday's end of day stock price of $5.63.

Health Catalyst's activity chart (see below) currently has 131 price targets and 137 ratings on display. The stock rating distribution of HCAT is 31.37% HOLD and 68.63% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.73% with an average time for these price targets to be met of 102.88 days.

Highest price target for HCAT is $12, Lowest price target is $7, average price target is $9.87.

Most recent stock forecast was given by STAN BERENSHTEYN from WELLS FARGO on 21-Jan-2025. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of HCAT, 16 are a HOLD (31.37%), 35 are a BUY (68.63%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$4.23 (73.31%)

$13

9 days ago
(21-Jan-2025)

2/5 (40%)

$4.51 (82.15%)

9

Buy

$10

$4.23 (73.31%)

$11

9 days ago
(21-Jan-2025)

4/12 (33.33%)

$4.51 (82.15%)

96

Hold

$7

$1.23 (21.32%)

$9

15 days ago
(15-Jan-2025)

8/14 (57.14%)

$1.28 (22.38%)

42

Buy

$10

$4.23 (73.31%)

$10.5

20 days ago
(10-Jan-2025)

3/10 (30%)

$2.96 (42.05%)

269

$9

$3.23 (55.98%)

$10

22 days ago
(08-Jan-2025)

0/3 (0%)

$1.67 (22.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 102.88 days on average for the stock forecasts to be realized with a an average price target met ratio 36.73

Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?

STEVEN HALPER

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Steven Halper has 9 price targets and 6 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Sandy Draper with highest potential upside - $50.22

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

John Ransom with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?